Guardant Health Newsroom

Morgan Stanley Maintains Guardant Health(GH.US) With Buy Rating, Cuts Target Price to $42

Futu NewsOct 31 21:40

Bernstein Maintains Outperform on Guardant Health, Lowers Price Target to $35

BenzingaOct 31 02:58

Craig-Hallum Maintains Guardant Health(GH.US) With Buy Rating

Futu NewsOct 23 21:31

Craig-Hallum Keeps Their Buy Rating on Guardant Health (GH)

TipRanksOct 23 20:57

Guardant Health Is Maintained at Outperform by Leerink Partners

Dow JonesOct 17 21:00

Guardant Health Analyst Ratings

BenzingaOct 17 20:52

Leerink Partners Maintains Guardant Health(GH.US) With Buy Rating, Cuts Target Price to $50

Futu NewsOct 17 20:31

Morgan Stanley Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $46

Futu NewsSep 17 19:31

CCORF Maintains Guardant Health(GH.US) With Buy Rating

Futu NewsAug 27 19:31

Buy Rating Affirmed for Guardant Health Amidst Expanding MRD Market and AI Integration

TipRanksAug 27 18:49

Nephron Research Downgrades Guardant Health to Sell From Hold, $23 Price Target

MT NewswiresAug 26 19:45

Scotiabank Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $47

Futu NewsAug 22 20:31

Scotiabank Keeps Their Buy Rating on Guardant Health (GH)

TipRanksAug 22 19:47

UBS Raises Price Target on Guardant Health to $40 From $32, Maintains Buy Rating

MT NewswiresAug 21 22:00

Guardant Health Analyst Ratings

BenzingaAug 21 21:52

UBS Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $40

Futu NewsAug 21 19:33

Guardant Health Analyst Ratings

BenzingaAug 13 23:22

Piper Sandler Maintains Overweight on Guardant Health, Raises Price Target to $34

BenzingaAug 13 23:22

Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and Prime Medicine, Inc. (PRME)

TipRanksAug 13 20:35

Piper Sandler Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $34

Futu NewsAug 13 19:33